SCHEMBL7970071

SCHEMBL7970071

Cc1cc(Cl)ccc1Nc1nc2ccccc2n2cncc12

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 18/20 0.72
LYN P07948 2/20 0.57
BTK Q06187 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969998 0.91 LCK (0.69) LCKLYNBTK
SCHEMBL7982170 0.88 LCK (0.79) LCK
SCHEMBL7982979 0.88 LCK (0.79) LCKLYNBTK
SCHEMBL7983457 0.86 LCK (0.74) LCK
SCHEMBL7970810 0.86 LCK (0.69) LCKLYNBTK
SCHEMBL7970038 0.85 LCK (0.64) LCKLYNBTK
SCHEMBL7981469 0.84 LCK (1.00) LCK
SCHEMBL7979597 0.81 LCK (0.83) LCK
SCHEMBL7969689 0.81 LCK (0.75) LCKLYNBTK
SCHEMBL7981428 0.80 LCK (0.80) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed